Target was Hit on AbbVie Inc. for a 13.6% Gain.

POST UPDATED: February 8, 2024

Table of Contents

Target was Hit on AbbVie Inc. (ABBV) at $162 for a 13.6 Gain. (Long Term Portfolio)


Become a Greenliner. Join Today

Candlestick. A Swing Traders Friend

A snapshot of the daily updates that help traders stay aligned with market direction.

Download our free ebook - Candlestick A swing traders friend